Biotech
Substrate AI Wins 1.7 million for 54 Ultrasound Machines for the Asturian Health System
Substrate AI acquired 4D Médica in 2022 for €1.4 million to boost its health sector, aiming to quadruple revenues to €2.8 million by 2023. The deal, financed partly by a Banco Santander loan, strengthens Substrate AI’s diverse portfolio, including agritech, fintech, and human resources. Samsung’s AI-driven ultrasound machines enhance telemedicine capabilities.
The Health Service of the Principality of Asturias (Sespa) has received 54 state-of-the-art ultrasound machines worth 1.7 million euros after the public contract was awarded in April 2024 to Diagximag, an Asturian company subsidiary of the company 4D Médica belonging to the Substrate AI group.
On September 30th, the final delivery agreement was signed for the equipment, which was supplied during the months of July and August, representing a very important step forward in terms of modernization and digitalization of the Asturian public health system.
These ultrasound machines feature Samsung’s artificial intelligence (AI)-based technology and the Sonosync function, which allows the radiologist to control the device remotely, controlling it outside the hospital premises, which represents a great advance in telemedicine, facilitating rapid diagnoses regardless of where the specialist is located.
Substrate AI bought 4D Médica in 2022 for 1.4 million euros
Substrate AI is a Spanish company in the field of AI specialized in the creation, acquisition and scaling of companies around this technology in sectors as diverse as health, finance or human resources. It owns several companies that market products and services based on the biologically inspired enhanced learning technology developed and patented by itself.
The company is currently listed on BME Growth, OTC Market and Aquis in London and, in addition to 4D Médica, it has in its portfolio PS Vet for the agritech sector , Zonavalue Global for the fintech area, SoyGuiri and Nabbu for the edtech area or Fleebe AI for human resources, among others.
The listed company announced the acquisition of 4D Médica in May 2022, for a value of 1.4 million euros . With the operation, Substrate AI intended to strengthen its health area, in which it then hoped to quadruple its revenues, reaching a turnover of 2.8 million euros in 2023.
Specifically, Substrate AI acquired 70% of the company in two equal parts. One was paid for with cash and the other through a loan from Banco Santander valued at 700,000 euros. This operation took place just a few days after the technology company’s stock market debut on the BME Growth.
__
(Featured image by MART PRODUCTION via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Africa2 weeks ago
Treasury Strategizes Amid Market Calm as Bank Al-Maghrib Boosts Liquidity Support
-
Fintech4 days ago
Deutsche Bank Develops Layer 2 for Ethereum – With Extras for Authorities
-
Biotech2 weeks ago
Quirónsalud and Roche Farma Sign an Agreement to Promote Healthcare Innovation and Research
-
Business3 days ago
TopRanked.io Weekly Affiliate Digest: What’s Hot in Affiliate Marketing [1xBet Partner Program Review]